Sanofi to invest 400 million euros in a mRNA vaccines facility

The French drug giant and its British counterpart GlaxoSmithKline surprised investors and customers late last year when they announced a one-year delay to the launch of their joint COVID vaccine, based on a more conventional technology.

from Moneycontrol Business News https://ift.tt/3A4XCyp